Document is current
Any future updates will be listed below
-
Authors
Simonini, Cecilia
Zucchi, Elisabetta
Martinelli, Ilaria
Gianferrari, Giulia
Lunetta, Christian
Sorarù, Gianni
Trojsi, Francesca
Pepe, Roberta
Piras, Rachele
Giacchino, Matteo
Banchelli, Federico
Mandrioli, Jessica
-
Funding
Funding for this research was provided by:
Ministero della Salute (Ricerca Corrente funding scheme of the Italian Ministry of Health, Ricerca Finalizzata bando 2021 (RF-2021-12373036))
Università Degli Studi di Modena e Reggio Emila (bando FAR 2021, Progetti di ricerca Interdisciplinari Mission Oriented, NEURALS project))
Fondazione Cassa di Risparmio di Modena (Neurobiobanca di Modena)
- License Information
-
More Information
Article History
Received: 13 December 2024
Accepted: 18 March 2025
First Online: 1 April 2025
Declarations
:
: The authors declare no competing interests.
: Each patient’s EAP for tofersen administration was approved by the local Ethical Committees of all the participating centers prior to enrolment,while this observational study received approval from the Ethics Committee of Area Vasta Emilia Nord (file number: 63/2022).
